| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/27/2011 | CN102036686A Water-containing composition |
| 04/27/2011 | CN102031278A Method for enzymatic synthesis of trehalose unsaturated fatty acid diester in organic phase |
| 04/27/2011 | CN102030922A Novel modified polysaccharide biomaterial used for eye administration and preparation process thereof |
| 04/27/2011 | CN102030908A Polyethyleneimine grafted guar gum cationic polymer and preparation method and application thereof |
| 04/27/2011 | CN102030907A Crosslinked polysiloxanes, a process for their preparation and use of the crosslinked polysiloxanes in emulsifier systems for water-in-oil emulsion |
| 04/27/2011 | CN102030898A ABC-type amphiphilic biodegradable polyester triblock copolymer and preparation method and application thereof |
| 04/27/2011 | CN102030891A TPGS-b-(PLA-ran-PGA) copolymer and preparation method and application thereof |
| 04/27/2011 | CN102030882A Method for preparing biodegradable polyurethane material with pH responsiveness |
| 04/27/2011 | CN102030871A Polyethylene glycol block biodegradable polyester comb-type graft copolymer, and preparation method and application thereof |
| 04/27/2011 | CN102030828A CTLA4-Ig fusion protein mutants with high affinity |
| 04/27/2011 | CN102030824A Monoclonal antibody of hepatitis B virus X protein and use thereof |
| 04/27/2011 | CN102030754A Non-viral vector, and preparation method and application thereof |
| 04/27/2011 | CN102028958A Composite tumor gene vaccine taking bacterial nano magnetosome as carrier and preparation method thereof |
| 04/27/2011 | CN102028955A Novel targeting compound for tumor gene interference |
| 04/27/2011 | CN102028954A Preparation of recombinant adenovirus |
| 04/27/2011 | CN102028953A Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells |
| 04/27/2011 | CN102028952A Galactan sulfate 5-fluorouracil compound and preparation and application thereof |
| 04/27/2011 | CN102028951A RGDfK-modified oridonin polylactic acid medicament-carrying nanoparticles and preparation method thereof |
| 04/27/2011 | CN102028950A Preparation for promoting stability of ceftriaxone sodium granules |
| 04/27/2011 | CN102028936A Method for preparing oral protein medicament |
| 04/27/2011 | CN102028927A Externally applied emplastrum for treating anxious chronic bronchitis and preparation method thereof |
| 04/27/2011 | CN102028896A Medical dropping pill for treating cough and preparation method thereof |
| 04/27/2011 | CN102028873A Tannin berberine gel for treating cervical erosion and preparation process thereof |
| 04/27/2011 | CN102028838A Oil liquid for treating burns and scalds |
| 04/27/2011 | CN102028836A Medicine dropping pill used for clearing heat and diminishing swelling and preparation method thereof |
| 04/27/2011 | CN102028825A Dental ulcer tablet containing dandelion and preparation method thereof |
| 04/27/2011 | CN102028801A Radix Rehmanniae oligosaccharide lung dosing traditional Chinese medicinal preparation as well as preparation method and application thereof |
| 04/27/2011 | CN102028749A Lyophilized powder injection for treating cardiovascular diseases and preparation method thereof |
| 04/27/2011 | CN102028711A Enzymatically synthesized triglyceride type fish oil soft capsules and preparation method thereof |
| 04/27/2011 | CN102028697A Non-ionic surface active agent-containing Latanoprost eye drop and preparation method thereof |
| 04/27/2011 | CN102028694A Application of Fasudil in preparing medicaments for treating glaucoma through ophthalmic drug delivery |
| 04/27/2011 | CN102028693A Rectal administration composite containing 5-phosphodiesterase inhibitor |
| 04/27/2011 | CN102028687A Nifedipine composition and preparation method thereof |
| 04/27/2011 | CN102028686A Valsartan amlodipine capsule and preparation method thereof |
| 04/27/2011 | CN102028684A Pharmaceutical composition containing tosufloxacin or salt thereof |
| 04/27/2011 | CN102028673A Flurbiprofen-containing external patch |
| 04/27/2011 | CN102028672A Microporous spongy film preparation and preparation method thereof |
| 04/27/2011 | CN102028671A Pioglitazone hydrochloride capsules and preparation method thereof |
| 04/27/2011 | CN102028668A Simvastatin osmotic pump controlled-release tablet |
| 04/27/2011 | CN102028667A Cefaclor sustained-release tablets and preparation method thereof |
| 04/27/2011 | CN102028666A Sustained release tablet containing famciclovir and preparation method thereof |
| 04/27/2011 | CN102028665A Nimodipine oral fast dissolving tablets and preparation method thereof |
| 04/27/2011 | CN102028664A Citicoline sodium tablets and preparation method thereof |
| 04/27/2011 | CN102028663A Stable olmesartan medoxomil solid preparation |
| 04/27/2011 | CN102028662A Levamlodipine besylate tablet, preparation process thereof and control method for relevant materials |
| 04/27/2011 | CN102028661A Pegylated recombinant human granulocyte colony stimulating factor freeze-dried powder/injection and preparation method thereof |
| 04/27/2011 | CN102028659A Valsartan bio-adhesive coated micro-pellet preparation and preparation method thereof |
| 04/27/2011 | CN102028654A Long-acting tylosin injection |
| 04/27/2011 | CN102028653A Injection administration preparation containing lamivudine |
| 04/27/2011 | CN102028630A Compositions comprising a superhydrophilic amphiphilic copolymer and a micellar thickener |
| 04/27/2011 | CN101669910B Preparation of cefobutazine sodium proliposome |
| 04/27/2011 | CN101647774B Asarone injection and preparation method thereof |
| 04/27/2011 | CN101632641B Lentinan lyophilized power injection and preparation method thereof |
| 04/27/2011 | CN101632637B Polyene taxol lipid preparation and method for preparing same |
| 04/27/2011 | CN101608006B Preparation method of double-network hydrogel |
| 04/27/2011 | CN101597338B Mannan-containing ligand and preparation method and application thereof |
| 04/27/2011 | CN101579306B Ciclopirox olamine pessary and preparation method thereof |
| 04/27/2011 | CN101547695B Aqueous liquid preparation having improved intraocular gatifloxacin penetration |
| 04/27/2011 | CN101543475B Tiamulin fumarate for veterinary use, lung-targeting microsphere of tiamulin fumarate salt and preparation method thereof |
| 04/27/2011 | CN101525789B Poly epsilon-caprolactone (PCL) and poly trimethylene methyl carbonic (PTMC) composite nanometer fiber and preparation and application thereof |
| 04/27/2011 | CN101513394B Continuous preparation method for nanometer dispersed vitamin A microcapsule |
| 04/27/2011 | CN101508429B Hydroxyapatite nano-complex particle, preparation and uses thereof |
| 04/27/2011 | CN101474151B Alkannin microemulsion composition |
| 04/27/2011 | CN101463131B Gamma-polyglutamic acid-asparaginic acid polymer and its complex, and preparation and use thereof |
| 04/27/2011 | CN101461813B Cefotiam hydrochloride preparation for injection and preparation method thereof |
| 04/27/2011 | CN101428003B Preparation of RGDF-fatty alcohol couplet mediated adriablastina target lipid and uses as anti-tumour agents |
| 04/27/2011 | CN101422432B Preparation method of tilmicosin nano-emulsion antibacterial drug |
| 04/27/2011 | CN101396351B Drug-loaded polyelectrolyte capsules in response to phosphatase concentration and preparation method thereof |
| 04/27/2011 | CN101361804B Enteral nutrition emulsion for tumor patient |
| 04/27/2011 | CN101327328B Dendrimers targeting nano particle and preparation and application thereof |
| 04/27/2011 | CN101327190B Anti-tumor long-circulating target liposomes for injections |
| 04/27/2011 | CN101292958B Method of preparing ultra-fine danazol powder |
| 04/27/2011 | CN101274096B Stable Batroxobin medicament composition |
| 04/27/2011 | CN101269059B Isosorbide dinitrate oral administration impulse pellet preparations |
| 04/27/2011 | CN101209240B Medicine gradient zero level implantation controlled-release drug administration device and preparation thereof |
| 04/27/2011 | CN101199623B Preparing method for treating hypertension drug slow controlled-release preparation |
| 04/27/2011 | CN101199496B Physical cross-bonding high molecular water resin Cataplasma substrate and preparing method thereof |
| 04/27/2011 | CN101130057B Long-acting implantation agent of pentapeptide for thymus gland and method of producing the same |
| 04/27/2011 | CN101068533B Pharmaceutical composition containing an anti-nucleating agent |
| 04/27/2011 | CN101062094B Total salvianolic acids long-cycle liposomes and the preparing method thereof |
| 04/27/2011 | CN101036654B Stable cefoperazone sulbactam medicine compound preparation |
| 04/26/2011 | US7932377 Complexing of medicinal substances with high-molecular carriers and injection and infusion solutions containing said complexes |
| 04/26/2011 | US7932367 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 04/26/2011 | US7932305 Viscous α-cyanoacrylate compositions |
| 04/26/2011 | US7932291 Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use |
| 04/26/2011 | US7932265 Solution formulations of sirolimus and its analogs for CAD treatment |
| 04/26/2011 | US7932241 Filling plastic container with bisphosphonate solution; heat sterilization |
| 04/26/2011 | US7932225 Glue composition for lung volume reduction |
| 04/26/2011 | US7931914 System and method for uniaxial compression of an article, such as a three-dimensionally printed dosage form |
| 04/26/2011 | US7931912 Enteral nutrition product and method for preparing the same |
| 04/26/2011 | US7931900 Method for the treatment of multiple sclerosis by inhibiting IL-17 activity |
| 04/26/2011 | US7931890 Targeted combination immunotherapy of cancer and infectious diseases |
| 04/26/2011 | CA2543350C Disintegratable films for diagnostic devices |
| 04/26/2011 | CA2504873C Percutaneous absorption preparation containing 3-methyl-1-phenyl-2-pyrazolin-5-one |
| 04/26/2011 | CA2490018C Method and packaging for pressurized containers |
| 04/26/2011 | CA2478771C Polymer composite with internally distributed deposition matter |
| 04/26/2011 | CA2454673C Topical pharmaceutical formulation |
| 04/26/2011 | CA2450728C Composition for the treatment of diseases which affect animals' hooves |
| 04/26/2011 | CA2446619C Permeation enhancers |
| 04/26/2011 | CA2441260C Insulin preparations, which do not contain any zinc or only a small quantity of zinc and which have an improved stability |